124 related articles for article (PubMed ID: 22414730)
21. RNA editing of the Q/R site of GluA2 in different cultured cell lines that constitutively express different levels of RNA editing enzyme ADAR2.
Yamashita T; Tadami C; Nishimoto Y; Hideyama T; Kimura D; Suzuki T; Kwak S
Neurosci Res; 2012 May; 73(1):42-8. PubMed ID: 22366356
[TBL] [Abstract][Full Text] [Related]
22. When Does ALS Start? ADAR2-GluA2 Hypothesis for the Etiology of Sporadic ALS.
Hideyama T; Kwak S
Front Mol Neurosci; 2011; 4():33. PubMed ID: 22102833
[TBL] [Abstract][Full Text] [Related]
23. Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2.
Hideyama T; Yamashita T; Suzuki T; Tsuji S; Higuchi M; Seeburg PH; Takahashi R; Misawa H; Kwak S
J Neurosci; 2010 Sep; 30(36):11917-25. PubMed ID: 20826656
[TBL] [Abstract][Full Text] [Related]
24. The AMPA receptor antagonist perampanel robustly rescues amyotrophic lateral sclerosis (ALS) pathology in sporadic ALS model mice.
Akamatsu M; Yamashita T; Hirose N; Teramoto S; Kwak S
Sci Rep; 2016 Jun; 6():28649. PubMed ID: 27350567
[TBL] [Abstract][Full Text] [Related]
25. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis.
Ishihara T; Ariizumi Y; Shiga A; Kato T; Tan CF; Sato T; Miki Y; Yokoo M; Fujino T; Koyama A; Yokoseki A; Nishizawa M; Kakita A; Takahashi H; Onodera O
Hum Mol Genet; 2013 Oct; 22(20):4136-47. PubMed ID: 23740936
[TBL] [Abstract][Full Text] [Related]
26. Phosphorylated TDP-43 becomes resistant to cleavage by calpain: A regulatory role for phosphorylation in TDP-43 pathology of ALS/FTLD.
Yamashita T; Teramoto S; Kwak S
Neurosci Res; 2016 Jun; 107():63-9. PubMed ID: 26723245
[TBL] [Abstract][Full Text] [Related]
27. Single-copy expression of an amyotrophic lateral sclerosis-linked TDP-43 mutation (M337V) in BAC transgenic mice leads to altered stress granule dynamics and progressive motor dysfunction.
Gordon D; Dafinca R; Scaber J; Alegre-Abarrategui J; Farrimond L; Scott C; Biggs D; Kent L; Oliver PL; Davies B; Ansorge O; Wade-Martins R; Talbot K
Neurobiol Dis; 2019 Jan; 121():148-162. PubMed ID: 30290270
[TBL] [Abstract][Full Text] [Related]
28. Deficient RNA editing of GluR2 and neuronal death in amyotropic lateral sclerosis.
Kwak S; Kawahara Y
J Mol Med (Berl); 2005 Feb; 83(2):110-20. PubMed ID: 15624111
[TBL] [Abstract][Full Text] [Related]
29. Motor neuron disease-associated loss of nuclear TDP-43 is linked to DNA double-strand break repair defects.
Mitra J; Guerrero EN; Hegde PM; Liachko NF; Wang H; Vasquez V; Gao J; Pandey A; Taylor JP; Kraemer BC; Wu P; Boldogh I; Garruto RM; Mitra S; Rao KS; Hegde ML
Proc Natl Acad Sci U S A; 2019 Mar; 116(10):4696-4705. PubMed ID: 30770445
[TBL] [Abstract][Full Text] [Related]
30. A system-wide mislocalization of RNA-binding proteins in motor neurons is a new feature of ALS.
Liu YJ; Kuo HC; Chern Y
Neurobiol Dis; 2021 Dec; 160():105531. PubMed ID: 34634461
[TBL] [Abstract][Full Text] [Related]
31. Newly identified ADAR-mediated A-to-I editing positions as a tool for ALS research.
Kwak S; Nishimoto Y; Yamashita T
RNA Biol; 2008; 5(4):193-7. PubMed ID: 18971634
[TBL] [Abstract][Full Text] [Related]
32. TDP-43 inclusions do not protect motor neurons from sporadic ALS.
Pamphlett R; Kum Jew S
Acta Neuropathol; 2008 Aug; 116(2):221-2. PubMed ID: 18521613
[No Abstract] [Full Text] [Related]
33. Sporadic amyotrophic lateral sclerosis with pallido-nigro-luysian degeneration: a TDP-43 immunohistochemical study.
Miki Y; Mori F; Nunomura J; Ookawa K; Yajima N; Yagihashi S; Wakabayashi K
Neuropathology; 2010 Apr; 30(2):149-53. PubMed ID: 19703266
[TBL] [Abstract][Full Text] [Related]
34. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration.
Melamed Z; López-Erauskin J; Baughn MW; Zhang O; Drenner K; Sun Y; Freyermuth F; McMahon MA; Beccari MS; Artates JW; Ohkubo T; Rodriguez M; Lin N; Wu D; Bennett CF; Rigo F; Da Cruz S; Ravits J; Lagier-Tourenne C; Cleveland DW
Nat Neurosci; 2019 Feb; 22(2):180-190. PubMed ID: 30643298
[TBL] [Abstract][Full Text] [Related]
35. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo.
Kabashi E; Lin L; Tradewell ML; Dion PA; Bercier V; Bourgouin P; Rochefort D; Bel Hadj S; Durham HD; Vande Velde C; Rouleau GA; Drapeau P
Hum Mol Genet; 2010 Feb; 19(4):671-83. PubMed ID: 19959528
[TBL] [Abstract][Full Text] [Related]
36. [Inefficient A-to-I RNA editing and ALS].
Kwak S
Rinsho Shinkeigaku; 2010 Nov; 50(11):978. PubMed ID: 21921533
[No Abstract] [Full Text] [Related]
37. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy.
Ihara R; Matsukawa K; Nagata Y; Kunugi H; Tsuji S; Chihara T; Kuranaga E; Miura M; Wakabayashi T; Hashimoto T; Iwatsubo T
Hum Mol Genet; 2013 Nov; 22(22):4474-84. PubMed ID: 23804749
[TBL] [Abstract][Full Text] [Related]
38. Effects of antidepressants on GluR2 Q/R site-RNA editing in modified HeLa cell line.
Sawada J; Yamashita T; Aizawa H; Aburakawa Y; Hasebe N; Kwak S
Neurosci Res; 2009 Jul; 64(3):251-8. PubMed ID: 19447293
[TBL] [Abstract][Full Text] [Related]
39. Altered astrocytic expression of TDP-43 does not influence motor neuron survival.
Haidet-Phillips AM; Gross SK; Williams T; Tuteja A; Sherman A; Ko M; Jeong YH; Wong PC; Maragakis NJ
Exp Neurol; 2013 Dec; 250():250-9. PubMed ID: 24120466
[TBL] [Abstract][Full Text] [Related]
40. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
